Back to Search
Start Over
Impact on T-cell depletion and CD34 + cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
- Source :
- Cytotherapy (Taylor & Francis Ltd); Jan2000, Vol. 2 Issue 1, p5-14, 10p
- Publication Year :
- 2000
-
Abstract
- Background : Ex vivo T-cell depletion of allogeneic BM (BM) grafts can effectively reduce graft versus host disease (GvHD) and may also apply to transplantation of allogeneic peripheral blood stem cell (PBSC) transplants. Methods : Here we have evaluated T-cell depletion and progenitor cell recovery by antibody-mediated cells lysis using three CD52 monoclonal antibodies (MAbs) at different concentrations and cell densities. Results : CAMPATH-1M was superior to CAMPATH-1H for T-cell depletion of BM samples. Treatment with CAMPATH-1M resulted in up to 2.55 log depletion of CD3 + cells, with recoveries of ≥45% CD34 + cells, ≥67% CFU-GM and ≥65% BFU-E. CAMPATH-1H treatment resulted in up to 1.64 log depletion of CD3 + cells and similar recoveries of CD34 + cells, CFU-GM and BFU-E as seen with CAMPATH-1M. Depletion of CD19 + cells was similar to that observed for CD3 + cells while natural killer (NK) cells were relatively spared compared with the T and B cell populations. Log depletions of T cells from PBSC, as determined by immunofluorescence studies and limiting dilution analyses, were similar using CAMPATH-1M, -1H, and -1G. There were also no differences in the depletion of CD19 + cells or NK cells using the three MAbs. Similar results were obtained for recoveries of CD34 + cells, CFU-GM and BFU-E using all three MAbs, although the recovery of CD34 + cells using the highest concentration of MAbs was significantly greater in CAMPATH-1H treated samples. Increasing the number of PBSC treated with CAMPATH-1H and -1M had no effect on the log depletion of T, B or NK cells and there were no major differences in the log depletions achieved with CAMPATH-1H or -1M. Likewise, the higher PBSC density had no effect on the recoveries of CD34 + cells or committed progenitors and once again CAMPATH-1H gave similar recoveries to those obtained using CAMPATH-1M. Discussion : Although CAMPATH-1M resulted in greater ex vivo T-cell depletion of BM than CAMPATH-1H, in all other respects, the humanised CAMPATH-1H was just as effective as CAMPATH-1M and -1G. [ABSTRACT FROM AUTHOR]
- Subjects :
- T cells
LYMPHOCYTES
MONOCLONAL antibodies
IMMUNOGLOBULINS
Subjects
Details
- Language :
- English
- ISSN :
- 14653249
- Volume :
- 2
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Cytotherapy (Taylor & Francis Ltd)
- Publication Type :
- Academic Journal
- Accession number :
- 10909501
- Full Text :
- https://doi.org/10.1080/146532400539008